Want to see FR:SAN full AI Analyst Report?

Sanofi (SAN) Stock Forecast & Price Target

337 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SAN Analyst Ratings

Moderate Buy

6 Buy

7 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Sanofi

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SAN Stock 12 Month Forecast

Average Price Target

€92.93

▲(18.02% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is €92.93 with a high forecast of €106.21 and a low forecast of €80.00. The average price target represents a 18.02% change from the last price of €78.74.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"72":"€72","107":"€107","80.75":"€80.8","89.5":"€89.5","98.25":"€98.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":106.21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€106.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":92.92818181818183,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€92.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€80.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[72,80.75,89.5,98.25,107],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.1,75.64692307692307,78.19384615384615,80.74076923076922,83.2876923076923,85.83461538461538,88.38153846153845,90.92846153846153,93.47538461538461,96.02230769230769,98.56923076923076,101.11615384615384,103.66307692307691,{"y":106.21,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.1,74.62524475524475,76.1504895104895,77.67573426573426,79.20097902097902,80.72622377622378,82.25146853146853,83.77671328671329,85.30195804195804,86.8272027972028,88.35244755244756,89.87769230769231,91.40293706293707,{"y":92.92818181818183,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.1,73.63076923076923,74.16153846153846,74.6923076923077,75.22307692307692,75.75384615384615,76.28461538461538,76.81538461538462,77.34615384615384,77.87692307692308,78.4076923076923,78.93846153846154,79.46923076923076,{"y":80,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":80.669,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.961,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.005,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.34,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.19,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.137,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.482,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.593,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.16,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.05,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.47,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.86,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.1,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€106.21

Average Price Target€92.93

Lowest Price Target€80.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Trung Huynh

RBC Capital

€80

Hold

1.60%

Upside

Reiterated

10/01/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT) and Eli Lilly & Co (NYSE: LLY)

Richard Vosser

J.P. Morgan

€95

Hold

20.65%

Upside

Reiterated

10/01/26

Analysts Conflicted on These Healthcare Names: Spyre Therapeutics (NASDAQ: SYRE), Sanofi (Other OTC: SNYNF) and Nektar Therapeutics (NASDAQ: NKTR)

Michael Leuchten

Jefferies

€100

Buy

27.00%

Upside

Reiterated

10/01/26

Sanofi (SNYNF) Gets a Buy from Jefferies

Emmanuel Papadakis

Deutsche Bank

€95

Buy

20.65%

Upside

Reiterated

09/29/26

Sanofi (SNYNF) Receives a Buy from Deutsche Bank

Matthew Weston

UBS

―

Hold

―

Reiterated

09/17/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Amgen (NASDAQ: AMGN) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)

Rajesh Kumar

HSBC

€95→€100

Buy

27.00%

Upside

Reiterated

09/10/26

Sanofi price target raised to EUR 100 from EUR 95 at HSBCSanofi price target raised to EUR 100 from EUR 95 at HSBC

James Gordon CFA

Barclays

€79→€83

Hold

5.41%

Upside

Reiterated

09/08/26

Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Merck & Company (NYSE: MRK)

Sachin Jain

Bank of America Securities

€92

Hold

16.84%

Upside

Reiterated

09/04/26

Bank of America Securities Remains a Hold on Sanofi (SNYNF)

Luisa Hector

Berenberg Bank

€105

Buy

33.35%

Upside

Reiterated

08/24/26

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (NASDAQ: RANI) and Sanofi (Other OTC: SNYNF)

Sarita Kapila

Morgan Stanley

€86→€82

Hold

4.14%

Upside

Reiterated

08/11/26

Sanofi price target lowered to EUR 82 from EUR 86 at Morgan StanleySanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley

Justin Smith

Bernstein

€107→€106.21

Buy

34.89%

Upside

Reiterated

08/04/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

07/31/26

Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Sanofi (SNYNF)

James Quigley

Goldman Sachs

€89→€84

Hold

6.68%

Upside

Reiterated

07/06/26

Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), Dogwood Therapeutics (NASDAQ: DWTX) and Sanofi (Other OTC: SNYNF)

Nicolas Pauillac

Kepler Capital

€85

Hold

7.95%

Upside

Reiterated

04/23/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)

Graham Parry

Citi

€85→€80

Hold

1.60%

Upside

Reiterated

02/20/26

Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Trung Huynh

RBC Capital

€80

Hold

1.60%

Upside

Reiterated

10/01/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Sagimet Biosciences, Inc. Class A (NASDAQ: SGMT) and Eli Lilly & Co (NYSE: LLY)

Richard Vosser

J.P. Morgan

€95

Hold

20.65%

Upside

Reiterated

10/01/26

Analysts Conflicted on These Healthcare Names: Spyre Therapeutics (NASDAQ: SYRE), Sanofi (Other OTC: SNYNF) and Nektar Therapeutics (NASDAQ: NKTR)

Michael Leuchten

Jefferies

€100

Buy

27.00%

Upside

Reiterated

10/01/26

Sanofi (SNYNF) Gets a Buy from Jefferies

Emmanuel Papadakis

Deutsche Bank

€95

Buy

20.65%

Upside

Reiterated

09/29/26

Sanofi (SNYNF) Receives a Buy from Deutsche Bank

Matthew Weston

UBS

―

Hold

―

Reiterated

09/17/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (Other OTC: SNYNF), Amgen (NASDAQ: AMGN) and BrightSpring Health Services, Inc. (NASDAQ: BTSG)

Rajesh Kumar

HSBC

€95→€100

Buy

27.00%

Upside

Reiterated

09/10/26

Sanofi price target raised to EUR 100 from EUR 95 at HSBCSanofi price target raised to EUR 100 from EUR 95 at HSBC

James Gordon CFA

Barclays

€79→€83

Hold

5.41%

Upside

Reiterated

09/08/26

Analysts Offer Insights on Healthcare Companies: Sanofi (Other OTC: SNYNF) and Merck & Company (NYSE: MRK)

Sachin Jain

Bank of America Securities

€92

Hold

16.84%

Upside

Reiterated

09/04/26

Bank of America Securities Remains a Hold on Sanofi (SNYNF)

Luisa Hector

Berenberg Bank

€105

Buy

33.35%

Upside

Reiterated

08/24/26

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (NASDAQ: RANI) and Sanofi (Other OTC: SNYNF)

Sarita Kapila

Morgan Stanley

€86→€82

Hold

4.14%

Upside

Reiterated

08/11/26

Sanofi price target lowered to EUR 82 from EUR 86 at Morgan StanleySanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley

Justin Smith

Bernstein

€107→€106.21

Buy

34.89%

Upside

Reiterated

08/04/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

07/31/26

Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Sanofi (SNYNF)

James Quigley

Goldman Sachs

€89→€84

Hold

6.68%

Upside

Reiterated

07/06/26

Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), Dogwood Therapeutics (NASDAQ: DWTX) and Sanofi (Other OTC: SNYNF)

Nicolas Pauillac

Kepler Capital

€85

Hold

7.95%

Upside

Reiterated

04/23/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)

Graham Parry

Citi

€85→€80

Hold

1.60%

Upside

Reiterated

02/20/26

Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

DFTXDefinium Therapeutics

OVIDOvid Therapeutics

ACHVAchieve Life Sciences

WSTWest Pharmaceutical Services

OMCLOmnicell

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sanofi

3 Months

David RisingerLeerink Partners

Success Rate

19/35 ratings generated profit

Average Return

-0.30%

Copying David Risinger's trades and holding each position for 3 Months would result in 54.29% of your transactions generating a profit, with an average return of -0.30% per trade.

1 Year

David RisingerLeerink Partners

Success Rate

20/35 ratings generated profit

Average Return

+2.24%

Copying David Risinger's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.24% per trade.

2 Years

Emmanuel PapadakisDeutsche Bank

Success Rate

22/55 ratings generated profit

Average Return

-2.71%

Copying Emmanuel Papadakis's trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -2.71% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SAN Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SAN has received 11 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. SAN average Analyst price target in the past 3 months is 92.93.

Each month's total comprises the sum of three months' worth of ratings.

SAN Financial Forecast

SAN Earnings Forecast

Next quarter’s earnings estimate for SAN is €2.78 with a range of €2.46 to €3.15. The previous quarter’s EPS was €2.09. SAN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SAN has Performed in-line its overall industry.

SAN Sales Forecast

Next quarter’s sales forecast for SAN is €13.64B with a range of €12.99B to €14.08B. The previous quarter’s sales results were €22.11B. SAN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SAN has Performed in-line its overall industry.

SAN Stock Forecast FAQ

What is FR:SAN’s average 12-month price target, according to analysts?

Based on analyst ratings, Sanofi’s 12-month average price target is 92.93.

What is FR:SAN’s upside potential, based on the analysts’ average price target?

Sanofi has 18.02% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Sanofi a Buy, Sell or Hold?

Sanofi has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 7 hold ratings and 0 sell ratings.

What is Sanofi’s share price target?

The average share price target for Sanofi is 92.93. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €106.21 ,and the lowest forecast is €80.00. The average share price target represents 18.02% Increase from the current price of €78.74.

What do analysts say about Sanofi?

Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Sanofi?

To buy shares of FR:SAN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Sanofi (SAN) Stock Forecast & Price Target

SAN Analyst Ratings

SAN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sanofi

SAN Analyst Recommendation Trends

SAN Financial Forecast

SAN Earnings Forecast

SAN Sales Forecast

SAN Stock Forecast FAQ

Detailed List of Analyst Forecasts